跳至主要内容
临床试验/CTRI/2025/09/094131
CTRI/2025/09/094131尚未招募不适用

EFFECT OF ANTENATAL CORTICOSTEROIDS FOR FETAL LUNG MATURITY ON GLYCEMIC STATUS IN PREGNANT WOMEN- AN OBSERVATIONAL STUDY

NIL SPONSOR1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2025年10月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
80
试验地点
1
主要终点
1 Change in maternal glycemic levels after ACS

研究概览

简要总结

In my study i will be including antenatal mothers including both Gestational diabetic and Non diabetic and are receiving corticosteroids indicated for development of fetal lung maturity and will monitor their CBG values at regular intervals to evaluate the impact of steroids in maternal glycemic variations and also effectively manage the rise in blood glucose values

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • 1 Age 18-45 yrs.
  • 2 Gestational age between 28 – 36 weeks.
  • 3 Planned for administration of antenatal corticosteroids.
  • 4 Willing to undergo Glycemic monitoring and provide informed consent.

排除标准

  • 1 Diabetic ketoacidosis 2 Women for whom the prescribed course of corticosteroid cannot be completed ( eg active labour).
  • 3 Suspected chorioamnionitis .
  • 4 Chronic steroid therapy or conditions requiring long-term steroid use.
  • 5 Severe maternal comorbidities (e.g., renal or hepatic dysfunction.

结局指标

主要结局

1 Change in maternal glycemic levels after ACS

时间窗: BASELINE | DAY 1 | DAY 3

2 Duration and persistence of hyperglycemia

时间窗: BASELINE | DAY 1 | DAY 3

3 Comparison between diabetic and non diabetic women

时间窗: BASELINE | DAY 1 | DAY 3

次要结局

  • 1 Proportion of diabetic AND non diabetic women requiring insulin or OHA post ACS(2 Risk factors associated with persistent or severe hyperglycemia)

研究者

发起方
NIL SPONSOR
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

UMAPRIYA C

MGMCRI

研究点 (1)

Loading locations...

相似试验